value-based care

ASCO, ESMO Value Frameworks Imperfectly Apply to Hematology

11/30/2016

JCP Editors

Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies, according to two studies presented at the 2016 ASH Annual Meeting and...

...

11/30/2016

Journal of Clinical Pathways

Research in Review

Treatment With Chemotherapy Drives Urothelial Cancer Resistance

10/21/2016

JCP Editors

Most patients with metastatic urothelial cancer will become resistant to therapy. New research published in Nature Genetics showed that chemotherapy also shapes the genetic evolution of remaining urothelial cancer...

Most...

10/21/2016

Journal of Clinical Pathways

Research in Review

COST Tool Measures Financial Toxicity of Patient Cancer Treatment

10/14/2016

JCP Editors

Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer....

Cancer...

10/14/2016

Journal of Clinical Pathways

Research in Review

Patient, Policymaker Conceptions of Value in Cancer Care Differ

10/07/2016

JCP Editors

New findings presented by the Cancer Support Community suggest that a significant proportion of patients have difficulty conceptualizing value in terms of current cost-benefit models used by...

New...

10/07/2016

Journal of Clinical Pathways

Department

Hypofractionated Radiation Therapy Offers Value-Based Care for Patients With Prostate Cancer

10/04/2016

JCP Editors

In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...

In the...

10/04/2016

Journal of Clinical Pathways

Research in Review

Value-Driven Outcomes Program Reduces Costs and Improves Quality

09/26/2016

JCP Editors

An analytic tool that allocates clinical care costs and quality measures to individual patient encounters may help to enhance the quality of care delivered by physicians, according to research published in JAMA. As...

An...

09/26/2016

Journal of Clinical Pathways

Research in Review

Vinblastine for Low-Grade Glioma Has Few Side Effects and Comparable Survival

09/09/2016

JCP Editors

Vinblastine monotherapy has similar outcomes and a more favorable toxicity profile compared with current therapies when used in patients with treatment naïve pediatric low-grade glioma (PLGG), according to a study...

...

09/09/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of September 4-10

09/08/2016

JCP Editors

In a Viewpoint found in the most recent issue of Journal of Clinical Pathways, Dr Stephen McKenna contends that oncology patient-reported outcome measures (PROMs) are restrictive because they focus too much on a...

In a...

09/08/2016

Journal of Clinical Pathways

Research in Review

Little Survival Benefit from WBRT in NSCLC Patients With Brain Metastasis

09/08/2016

JCP Editors

Patients with non-small cell lung cancer and brain metastasis can be spared whole brain radiotherapy (WBRT), as it does little or has no effect on survival and quality of life, according to a study published in The...

...

09/08/2016

Journal of Clinical Pathways

Counterpoint

Incorporating Routine Patient-Reported Outcomes Assessment Into Cancer Care: Building Momentum

09/06/2016

Edward Stepanski, PhD

While the collection and reporting of patient-reported outcome data in oncology trials and care settings has yet to reach its full potential, it has made some progress in recent years. Patient-reported outcomes...

While...

09/06/2016

Journal of Clinical Pathways